Bausch Health Americas, Inc.

This study is observing how people in Canada feel about using a prescription acne gel in their regular care. About 200 participants aged 12 and older will use the gel and report on their satisfaction, how well they stick to the treatment, and any side effects over 20 weeks. The g…

This study is monitoring the long-term safety of the psoriasis medication brodalumab compared to other treatments. It will follow 3,500 adults with moderate-to-severe psoriasis who are already starting or switching to a systemic treatment as part of their regular care. The main g…

This study is checking the safety and how the body processes a single dose of the drug brodalumab in children aged 6 to 18 with severe plaque psoriasis. It is a small, early-stage study designed to gather initial safety information. The main goal is to see how much of the drug ge…

This study is observing adults in Canada who are starting the psoriasis medication brodalumab as part of their regular care. Researchers will follow about 500 participants for one year to see how the treatment affects their quality of life, work productivity, and daily activities…

This early-stage study aimed to test whether inhaled Virazole (ribavirin) could help hospitalized adults with COVID-19 who were experiencing serious breathing problems. The trial planned to measure whether the treatment improved patients' breathing and overall condition. However,…

This study is testing whether a medication called rifaximin can delay the first serious brain complication in people with advanced liver disease (cirrhosis) who have controlled fluid buildup in their abdomen. About 466 participants will receive either the medication or a placebo …

This study is testing how well and how safely a newer version of the Fraxel laser works for improving skin appearance. It will involve about 50 adults with sun damage, discoloration, or wrinkles around the eyes. Participants will receive three laser treatments, and doctors will m…

This is a long-term safety study, not a treatment trial. Researchers are following 8,000 children and teens with eczema for 10 years to see if using Elidel cream (pimecrolimus) increases their risk of developing cancers like lymphoma. The study is observing children who have alre…